NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: BYND 32.83%
Expected US Company Earnings on Wednesday, February 25th, 2026
NASDAQ: PRAA 32.17%
PRA Group (PRAA) Q4 2025 Earnings Call Transcript
NYSE: BATL 21.08%
Halftime Market Summary: Stocks to Watch before Super Bowl Weekend
NASDAQ: ENSC 73.31%
Expected US Company Earnings on Tuesday, November 11th, 2025
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
OTC: NGNE 32.83%
OTC: BYND 32.83%
OTC: PRAA 32.83%
OTC: BATL 32.83%
OTC: ENSC 32.83%
